Literature DB >> 6192222

Chronic relapsing experimental allergic encephalomyelitis: its value as an experimental model for multiple sclerosis.

H Lassmann.   

Abstract

Comparison of the pathohistology of chronic relapsing experimental allergic encephalomyelitis (CR-EAE) and multiple sclerosis (MS) reveals a close similarity. Thus, CR-EAE appears to be a valuable model for the study of pathogenetic factors leading to the formation of MS lesions, although the induction of the disease may be different (active sensitization with CNS antigens and adjuvant in CR-EAE versus unknown etiology in MS). CR-EAE furthermore mimicks the pathohistological patterns of other related human inflammatory demyelinating diseases (i.e., acute perivenous leukoencephalomyelitis and acute hemorrhagic leukoencephalomyelitis). The expression of an acute, predominantly inflammatory versus chronic inflammatory demyelinating disease in this model depends upon the time interval between sensitization and sampling of the animals. Recent evidence is discussed that a cooperation between cellular and humoral immune mechanisms, directed against multiple CNS antigens, is responsible for the formation of large demyelinated plaques in EAE and MS.

Entities:  

Mesh:

Year:  1983        PMID: 6192222     DOI: 10.1007/bf00313549

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  55 in total

1.  The isolation from bovine spinal cord of a homogeneous protein with encephalitogenic activity.

Authors:  E R EINSTEIN; D M ROBERTSON; J M DICAPRIO; W MOORE
Journal:  J Neurochem       Date:  1962 Jul-Aug       Impact factor: 5.372

2.  [Genesis of acute demyelinating encephalitis].

Authors:  F SEITELBERGER; K JELLINGER; H TSCHABITSCHER
Journal:  Wien Klin Wochenschr       Date:  1958-06-20       Impact factor: 1.704

3.  Chronic experimental allergic encephalomyelitis in monkeys.

Authors:  A FERRARO; C L CAZZULLO
Journal:  J Neuropathol Exp Neurol       Date:  1948-07       Impact factor: 3.685

4.  Experimental allergic encephalomyelitis--migration of early T cells from the circulation into the central nervous system.

Authors:  U Traugott; S H Stone; C S Raine
Journal:  J Neurol Sci       Date:  1978-03       Impact factor: 3.181

5.  Acute and chronic autoimmune encephalomyelitis: age, strain, and sex dependency. The importance of the source of antigen.

Authors:  S H Stone; E M Lerner; J H Goode
Journal:  Proc Soc Exp Biol Med       Date:  1969-10

6.  Relapsing experimental allergic encephalomyelitis induced with isolated myelin and with myelin basic protein plus myelin lipids.

Authors:  R E Madrid; H M Wiśniewski; K Iqbal; R K Pullarkat; H Lassmann
Journal:  J Neurol Sci       Date:  1981-06       Impact factor: 3.181

7.  Induction of recurrent experimental allergic encephalomyelitis with myelin basic protein.

Authors:  H Panitch; C Ciccone
Journal:  Ann Neurol       Date:  1981-05       Impact factor: 10.422

8.  Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion.

Authors:  C S Raine; L Scheinberg; J M Waltz
Journal:  Lab Invest       Date:  1981-12       Impact factor: 5.662

9.  Cerebroside antibody inhibits sulfatide synthesis and myelination and demyelinates in cord tissue cultures.

Authors:  J M Fry; S Weissbarth; G M Lehrer; M B Bornstein
Journal:  Science       Date:  1974-02-08       Impact factor: 47.728

10.  ENCEPHALOMYELITIS ACCOMPANIED BY MYELIN DESTRUCTION EXPERIMENTALLY PRODUCED IN MONKEYS.

Authors:  T M Rivers; F F Schwentker
Journal:  J Exp Med       Date:  1935-04-30       Impact factor: 14.307

View more
  13 in total

1.  Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.

Authors:  Derrick P McCarthy; Maureen H Richards; Stephen D Miller
Journal:  Methods Mol Biol       Date:  2012

Review 2.  A review of the etiology of multiple sclerosis.

Authors:  V Vella
Journal:  Ital J Neurol Sci       Date:  1984-12

3.  Immunological treatment of multiple sclerosis.

Authors:  R A Hughes
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

4.  Mechanisms and pharmacology of neuropathic pain in multiple sclerosis.

Authors:  T Iannitti; B J Kerr; B K Taylor
Journal:  Curr Top Behav Neurosci       Date:  2014

5.  Preventive and therapeutic effects of cyclosporin and valine2-dihydro-cyclosporin in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat.

Authors:  C Feurer; L H Chow; J F Borel
Journal:  Immunology       Date:  1988-02       Impact factor: 7.397

Review 6.  Assessing optic nerve pathology with diffusion MRI: from mouse to human.

Authors:  Junqian Xu; Shu-Wei Sun; Robert T Naismith; Abraham Z Snyder; Anne H Cross; Sheng-Kwei Song
Journal:  NMR Biomed       Date:  2008-11       Impact factor: 4.044

7.  Peripheral blood T lymphocyte changes in multiple sclerosis: a marker of disease progression rather than of relapse?

Authors:  A J Thompson; J Brazil; C A Whelan; E A Martin; M Hutchinson; C Feighery
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-08       Impact factor: 10.154

8.  Live cell imaging techniques to study T cell trafficking across the blood-brain barrier in vitro and in vivo.

Authors:  Caroline Coisne; Ruth Lyck; Britta Engelhardt
Journal:  Fluids Barriers CNS       Date:  2013-01-21

9.  Quantitative Analysis of Mouse Retinal Layers Using Automated Segmentation of Spectral Domain Optical Coherence Tomography Images.

Authors:  Chantal Dysli; Volker Enzmann; Raphael Sznitman; Martin S Zinkernagel
Journal:  Transl Vis Sci Technol       Date:  2015-08-25       Impact factor: 3.283

10.  NMR-Based Metabolomics Separates the Distinct Stages of Disease in a Chronic Relapsing Model of Multiple Sclerosis.

Authors:  Alex M Dickens; James R Larkin; Benjamin G Davis; Julian L Griffin; Timothy D W Claridge; Nicola R Sibson; Daniel C Anthony
Journal:  J Neuroimmune Pharmacol       Date:  2015-07-09       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.